DNA hypermethylation is associated with invasive phenotype of malignant melanoma-Reference-Cited by-同舟云学术

DNA hypermethylation is associated with invasive phenotype of malignant melanoma

Published:2019-11-14 Issue:1 Volume:29 Page:39-50
ISSN:0906-6705
Container-title:Experimental Dermatology
language:en
Short-container-title:Exp Dermatol

Author:

Koroknai Viktória¹²,Szász István¹²,Hernandez‐Vargas Hector³,Fernandez‐Jimenez Nora³,Cuenin Cyrille³,Herceg Zdenko³,Vízkeleti Laura¹²,Ádány Róza¹²,Ecsedi Szilvia¹²³,Balázs Margit¹²^ORCID

Affiliation:

1. Public Health Research Institute University of Debrecen Debrecen Hungary

2. MTA‐DE Public Health Research Group Public Health Research Institute University of Debrecen Debrecen Hungary

3. Epigenetics Group International Agency for Research on Cancer (IARC) Lyon France

Publisher

Wiley

Subject

Dermatology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/exd.14047

Reference84 articles.

1. Melanoma revives an embryonic migration program to promote plasticity and invasion

2. Melanoma: From Melanocyte to Genetic Alterations and Clinical Options

3. Initial steps of metastasis: Cell invasion and endothelial transmigration

4. Tumor Metastasis: Molecular Insights and Evolving Paradigms

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cuproptosis-related gene-located DNA methylation in lower-grade glioma: Prognosis and tumor microenvironment;Cancer Biomarkers;2024-07-01

2. Unveiling the role of RAC3 in the growth and invasion of cisplatin‐resistant bladder cancer cells;Journal of Cellular and Molecular Medicine;2024-06

3. Machine Learning Methods for Gene Selection in Uveal Melanoma;International Journal of Molecular Sciences;2024-02-01

4. Integrated DNA methylation analysis reveals a potential role for PTPRN2 in Marfan syndrome scoliosis;JOR SPINE;2024-01-29

5. Comparative Analysis of the Effect of the BRAF Inhibitor Dabrafenib in 2D and 3D Cell Culture Models of Human Metastatic Melanoma Cells;In Vivo;2024